A. “Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events,” by Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, Yuji Miura, Takanobu Motoshima, Kosuke Imamura, Toshiki Kimura, Tokunori Ikeda, Yukio Fujiwara, Hiromu Yano, Tomomi Kamba, Takuro Sakagami and Hiroyuki Oshiumi (Vol. 119, No. 29, July 19, 2022, e2205378119).
www.pnas.org/doi/abs/10.1073/pnas.2205378119
B. “Therapeutic functions of astrocytes to treat {alpha}-synuclein pathology in Parkinson’s disease,” by Yunseon Yang, Jae-Jin Song, Yu Ree Choi, Seong-hoon Kim, Min-Jong Seok, Noviana Wulansari, Wahyu Handoko Wibowo Darsono, Oh-Chan Kwon, Mi-Yoon Chang, Sang Myun Park and Sang-Hun Lee (Vol. 119, No. 29, July 19, 2022, e2110746119).
